Association of Interleukin-10 gene promoter polymorphisms in Saudi patients with Vitiligo

Disease Markers

Volumn 24, Issue 1, 2008, Pages 51-57

  Abanmi, Abdullah ^a   Al Harthi, Fahad ^a   Zouman, Abdulrahman ^a   Kudwah, Aida ^a   Al Jamal, Mohammed ^a   Arfin, Misbahul ^a   Tariq, Mohammad ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Interleukin 10; Polymorphism; Saudis; Vitiligo

Indexed keywords

INTERLEUKIN 10;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SAUDI ARABIA; VITILIGO;

EID: 36448988923     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/210609     Document Type: Article

References (64)

1. A. Alkhateeb, P.R. Fain, A. Thody, D.C. Bennett and R.A. Spritz, Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families, Pigment Cell Res 16 (2003), 208-214.
2. A. Birol, U. Kisa, G.S. Kurtipek, F. Kara, M. Kocak, E. Erkak et al., Increased tumor necrosis factor alpha (TNF-α) levels and Interleukin 1 alpha (IL1-α) levels in the lesional skin of patients with non-segmental vitiligo, I J Dermatol 45 (2006), 992-993.
3. A.G. Wilson, J.A. Symons, T.L. McDowell, H.O. McDevit and G.W. Duff, Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation, Proc Nat Acad Sci 94 (1997), 3195-3199.
4. A. Marchant, J. Deviere, B. Byl, D. De Groote, J.L. Vincent and M. Goldman, Interleukin-10 production during septicemia, Lancet 343 (1994), 707-708.
5. A. Savejgaard, P. Platz and L.P. Ryder, HLAand disease 1982-A survey, Immunol Rev 70 (1983), 193-218.
6. A. Wankowicz-Kalinska, C. Le Poole, R. van den Wijngaard, W.J. Sorkus and P.K. Das, Melanocyte-Specific immune Response in melanoma and vitiligo: Two faces of the same coin, Pigment Cell Res 16 (2003), 254-260.
7. C.M. Shih, Y.L. Lee, H.L. Chiou, W.F. Hsu, W.E. Chen, M.C. Chou and L.Y. Lin, The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer, Lung Cancer 50 (2005), 291-297.
8. C. Perrey, S. Turner, V. Pravica, W.M. Howell and I.V. Hutchinson, ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms, Transplant Immunol 7 (1999), 127-128.
9. C. Seifart, A. Plagens, A. Dempfle, U. Clostermann, C. Vogelmeier, P. vonWichert and U. Seifart, TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer, Dis Markers 21 (2005), 157-165.
10. D.F. Florentino, P. Zlotnik, P. Vieira, T.R. Mosmann, M. Howard, K.W. Moore and A. O'Garra, IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells, J Immunol 146 (1991), 3444-3451.
11. D. Kube, C. Platzer, A. Von Koethen, H. Traub, H. Bohleen, M. Hafner and M. Tesch, Characterization of the promoter activity in Burkitt's lymphoma cell lines, Cytokine 7 (1995), 1-7.
12. D.M. Turner, D.M. Williams, D. Sankaran, M. Lazarus, P.J. Sinnott and I.V. Hutchinson, An investigation of polymorphism in the interleukin-10 gene promoter, Eur J Immunogenet 24 (1997), 1-8.
13. D. Malhotra, K. Darvishi, S. Sood, S. Sharma, C. Grover, V. Relhan, B.S. Reddy and R.N. Bamezai, IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy, Hum Genet 118 (2005), 295-300.
14. E. Crawley, R. Kay, J. Sillibourne, P. Patel, I. Hutchinson and P. Woo, Polymorphic haplotypes of the interleukin-10 5′flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis, Arthritis Rheum 42 (1999), 1101-1108.
15. E.M. Shajil, S. Chatterjee, D. Agrawal, T. Bagchi and R. Begum, Vitiligo: pathomechanism and genetic polymorphism of susceptible genes, Indian J Exp Biol 44 (2006), 526-539.
16. E.M. Simmons, J. Himmelfarb, M.T. Sezer, G.M. Chertow, R.L. Mehta, E.P. Paganini, S. Soroko, S. Freedman, K. Becker, D. Spratt et al., Plasma cytokine levels predict mortality in patients with acute renal failure, Kidney Int 65 (2004), 1357-1365.
17. E.V. Fowler, R. Eri, G. Hume, S. Johnstone, N. Pandeya, D. Lincoln, D. Templeton and G.L. Radford-Smith, TNF alpha and IL10 SNPs act together to predict disease behavior in Crohn's disease, J Med Genet 42 (2005), 523-528.
18. F. Rousset, E. Garcia, T. Defrance, N. Vezzio, C. Peronne, D.H. Hsu, R. Kastellein, K.W. Moore and J. Banchereau, Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes, Proc Natl Acad Sci USA 89 (1992), 1890-1893.
19. F.Y. Yue, R. Dummer, R. Geertsen, G. Hofbauer, E. Laine, S. Manolio and G. Burg, Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules, Int J Cancer 71 (1997), 630-637.
20. G. He, J. Zhang, X.W. Li, W.Y. Chen, Y.X. Pan, F.P. Yang, N.F. Gu, G.Y. Feng, S.L. Yang, J.Y. He, B.X. Liu, Y.W. Peng, J. Liu and L. He, Interleukin-10-1082 promoter polymorphism is associated with schizophrenia in a Han Chinese sib-pair study, Neurosci Lett 394 (2006), 1-4.
21. G. Monneret, M.E. Finck, F. Venet, A.L. Debard, J. Bohe, J. Bienvenu and A. Lepape, The anti-inflammatory response dominates after septic shock: association of low moncyte HLA-DR expression and high interleukin-10 concentration, Immunol Lett 95 (2004), 193-198.
22. H.D. Shin, B.L. Park, Y.H. Kim, H.S. Cheong, I.H. Lee and S.K. Park, Common interleukin 10 polymorphism associated with decreased risk of tuberculosis, Exp Mol Med 37 (2005), 128-132.
23. I.C. LePoole, P.K. Das, R.M.G.J. van den Wijngaard, J.D. Bos and W. Westerhof, Review of the etiopathomechanism of vitiligo: a convergence theory, Exp Dermatol 2 (1993), 145-153.
24. I.V. Hutchinson, D. Turner, D. Sankaran, M. Awad, V. Pravica and P. Sinnott, Cytokine genotypes in allograft rejection: guidlines for immunosuppression, Transplant Proc 30 (1998), 3991-3992.
25. J. Bidwell, L. Keen, G. Gallachar, R. Kimberly, T. Huizinga, M.F. McDermott, J. Oksenberg, J. McNicholl, F. Pociot, C. Hardt and S. D'Alfonso, Cytokine gene polymorphism in human disease: on-line databases, Genes Immun 1 (1999), 3-19.
26. J.C. Zeller, A. Panoskaltsis-Mortari, W.J. Murphy, F.W. Ruscetti, S. Narula, M.G. Roncarolo and B.R. Blazar, Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta, J Immunol 163 (1999), 3684-3691.
27. J. Eskdale, D. Kube, H. Tesch and G. Gallagher, Mapping of the human IL10 gene and further characterization of the 5′flanking sequence, Immunogenetics 46 (1997), 120-128.
28. J. Karjalainen, J. Hulkkonen, M.M. Nieminen, H. Huhtala, A. Aromaa, T. Klaukka and M. Hurme, Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma, Clin Exp Allergy 33 (2003), 78-83.
29. J.M. Kim, C.I. Brannan, N.G. Copeland, N.A. Jenkins, T.A.K.W. Khan and K.W Moore, Structure of the mouse IL10 gene and chromosomal localization of the mouse and human genes, J Immunol 148 (1992), 3618-3623.
30. J. Wang, H. Ni, L. Chen, W.Q. Song, Interleukin-10 promoter polymorphism in patients with hepatitis B virus infection or hepatocellular carcinomain Chinese Han ethnic population, Hepatobiliary Pancrat Dis Int 5 (2006), 60-64.
31. K.E. Sharquie, S.H. Mehenna, A.A. Naji and M. Al-Azzawi, Inflammatory changes in vitiligo: stage II depigmentation, Am J Dermatopathol 26 (2004), 108-112.
32. K.U. Schallreuter, C. Levenig, P. Kuhnl, C. Loliger, M. Hohl-Tehari and J. Berger, Histocompatability antigens in vitiligo: Hamburg study on 102 patients from Northern Germany, Dermatology 187 (1993), 186-192.
33. K.W. Moore, A. O'Garra, R. de Waal Malefyt, P. Vieira and T.R. Mosman, Interleuikin-10, Annu Rev Immunol 11 (1993), 165-190.
34. K.W. Moore, R. de Waal Malefyt, R.L. Coffman and A. O'Garra, Interleukin-10 and the interleukin-10 receptor, Annu Rev Immunol 19 (2001), 683-765.
35. K. Zhang, P. Hei, L. Deng and J. Lin, Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis, Mol Hum Reprod 13 (2007), 135-140.
36. L. Fernandez, A. Martinez, J.L. Mendoza, E. Urcelay, M. Fernandez-Arquero, J. Garcia-Paredes, M. Diaz-Rubio and E.G. de la Concha, Interleukin-10 polymorphisms in Spanish patients with IBD, Inflamm Bowel Dis 11 (2005), 739-743.
37. M. Addas-Carvalho, T.S.I. Salles and S.T.O. Saad, The association of cytokine gene polymorphism with febrile nonhemolytic transfusion reaction in multitransfused patients, Transfusion Med 19 (2006), 184-191.
38. M. Arcos-Burgos, E. Parodi, M. Salgar, E. Bedya, J. Buile and D. Jaramillo, Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA, Hum Genet 110 (2002), 334-342.
39. M. Howard and A. O'Garra, Biological properties of interleukin 10, Immunol Today 13 (1992), 198-200.
40. M. Luomala, T. Lehtimaki, H. Huhtala, M. Ukkonen, T. Koivula, M. Hurme and I. Elovaara, Promoter polymorphism of IL-10 and severity of multiple sclerosis, Acta Neurol Scand 108 (2003), 396-400.
41. M. Lyon, C. Lange, S. Lake, E.K. Silverman, A.G. Randolph, D. Kwiatkovaski, B.A. Raby, R. Lazarus, K.M. Weiland. N. Laird and S.T. Weiss, IL-10 gene polymorphisms are associated with asthma in children, Genet Epidemiol 26 (2004), 155-165.
42. M.N. Gong, B.T. Thompson, P.L. Williams, W. Zhou, M.Z. Wang, L. Pothier and D.C Christiani, Interleukin-10 polymorphism in position - 1082 and acute respiratory distress syndrome, Eur Respir J 27 (2006), 674-681.
43. N. Gavalas, S. Akhtar, D. Gawkrodger, P. Watson, A. Weetman and E.H. Kemp, Analysis of allelic variats in the catalase gene in patients with the skin depigmenting disorder vitiligo. Biochem Biophy Res Commun 345 (2006), 1586-1591.
44. P.D. Katsikis, C.Q. Chu, F.M. Brennan, R.N. Maini, M. Feldmann, Immunoregulatory role of interleukin 10 in rheumatoid arthritis, J Exp Med 179 (1994), 1517-1527.
45. P.E. Grimes, R. Morris, E. Avaniss-Aghajani, T. Soriano, M. Meraz and A. Metzger, Topical tracolimus therapy for vitiligo: Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines, J Am Acad Dermtol 51 (2004), 52-61.
46. P.G. Vidigal, J.J. Germer and N.N. Zein, Polymorphism in the interleukin-10, tumor necrosis factor-alpha and transforming growth factor beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin, I J Heptol 36 (2006), 271-277.
47. P.P. Majumder, J. J. Nordlund and S.K. Nath, Pattern of familial aggregation of vitiligo, Arch Dermatol 129 (1993), 994-998.
48. Q. Shu, X. Fang, Q. Chen and F. Stuber, IL-10 polymorphism is associated with increased incidence of severe sepsis, Chin Med J (Engl) 116 (2003), 1756-1759.
49. R.A. Spritz, K. Gowan, D.C. Bennet and P.R. Fain, Novel vitiligo susceptibility loci on chromosome 7 (AIS2) and (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis, Am J Hum Genet 74 (2004), 188-191.
50. R. de Waal Malefyt, J. Abrams, B. Bennett, C.G. Figdor and J.E. de Vries, Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes, J Exp Med 174 (1991), 1209-1220.
51. R. deWaal Malefyt, J. Haanen, H. Spits, M.G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel and J.F. de Vries, Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression, J Exp Med 174 (1991), 915-924.
52. R.G. Westendorp, J.A. Langermans, T.W. Huizinga, C.L. Verwiej and A. Sturk, Genetic influences on cytokine production and fatal meningococcal disease, Lancet 349 (1997), 170-173.
53. R. Neidhardt, M. Keel, U. Steckholzer, A. Safret, U. Ungethuem, O. Trentz and W. Ertel, Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients, J Trauma 42 (1997), 863-870.
54. S.A. Stanilova, L.D. Miteva, Z.T. Karakolev and C.S. Stefanov, Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility, Intensive Care Med 32 (2006), 260-266.
55. S.K. Nath, J.B. Harley and Y.H. Lee, Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis Hum Genet 118 (2005), 225-234.
56. S.K. Nath, P.P. Majumder and J.J. Nordlund, Genetic epidemiology of vitiligo: multilocus recessivity cross-validated, Am J Hum Genet 55 (1994), 981-990.
57. S.L. Ma, N.L Tang, L.C. Lam and H.F. Chiu, The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease, Neurobiol Aging 26 (2005), 1005-1010.
58. S. Moretti, A. Spallanzani, L. Amato, G. Hautmann, I. Gallerani, M. Fabiani and P. Fabbri, New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions, Pigment Cell Res 15 (2002), 87-92.
59. T.R. Mosmann, Properties and functions of interleukin-10, Adv Immunol 56 (1994), 1-10.
60. T. Tsuruma, A. Yagihashi, T. Torigoe, N. Sato, K. Kijuchi, N. Watanabe and K. Hirata, Interleukin-10 reduces natural killer sensitivity and down regulates MHC class I expression on H-ras-Transformed cells, Cell Immunol 184 (1998), 121-128.
61. T.W. Huizinga, V. Keijsers, G. Yanni et al., Are differences in interleukin 10 production associated with joint damage? Rheumatology 39 (2000), 1180-1188.
62. U. Langsenlehner, P. Krippl, W. Renner, B. Yazdani-Biuki, T. Eder, H. Koppel, T.C. Wascher, B. Paulweber and H. Samonigg, Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk, Breast Cancer Res 90 (2005), 113-115.
63. Y. Honda, Y. Okubo and M. Koga, Relationship between levels of soluble interleukin-2 receptors and the types of activity of vitiligo, J Dermatol 24 (1997), 561-563.
64. Y.H. Chang, C.N. Huang, C.Y. Wu and M.Y. Shiau, Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus, Hum Immunol 66 (2005), 1258-1263.